entertainment -WSS

entertainment

author：hotspot 2025-09-06 01:58:52 - browse：615

Illustration of a prescription bottle image on the screen of a smart phone – medical tech coverage from STAT — Alex Hogan/STAT

In another sign of the business headwinds facing prescription mental health apps, developer Twill will shop around for a pharmaceutical company to market Aspiro, its cognitive behavioral therapy treatment for both generalized anxiety and major depression.

Twill executives told STAT the company hopes that a drugmaker developing or currently marketing a product for generalized anxiety, or GAD, and major depressive disorder, or MDD, will be interested in adding a digital therapeutic to boost the effect of its drug — as well as its sales. Twill’s chief strategy officer Chris Wasden said that after watching companies built around prescription digital therapeutics, or PDTs, stall out, Twill made the decision earlier this year that it would only take the product to market if it found a willing drugmaker to serve as its partner.

“A PDT is going to be more valuable in the hands of a drug company that has a drug that they would like to get greater adherence [and] greater revenues from rather than trying to get reimbursement for the PDT itself,” he said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Head of FDA's diagnostics center, who led through Covid, retires

WSS

Devoted Health’s losses in Medicare Advantage persist

The inclusion problem at the heart of rehabilitation research

Immunocompromised patients offer clues on chronic Covid

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

Surgery pushed Ben Carson to fame

340B reform proposal comes out of Senate working group

leisure time

entertainment

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

Problems with a popular proposal to regulate AI in health care

In Memoriam: Notable people who died in 2023

FDA endorses new sterilization method for medical devices

Dobbs anniversary: the lost opportunity of abortion as health care

Prior authorization reform is both possible and imperative

New air purifier tech could be key to improving indoor air quality

To bolster infectious disease surveillance, genomics powerhouses team up

Cancer drug shortages should be causing more outrage

340B reform proposal comes out of Senate working group

hotspot

What’s missing from the debate over nursing home staff minimums

AstraZeneca stays mum on Medicare drug pricing negotiations

Readout Newsletter: Amgen, Regeneron, BGI Group and more

What’s missing from the debate over nursing home staff minimums

CVS is on a mission to consolidate health care. Will it work?

Bernie brings in new pharma CEOs to talk drug prices

leisure time

hotspot

hotspot

hotspot